An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study [of lamotrigine] in Healthy, Adult, Human Subjects Under Fed Conditions.

Trial Profile

An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study [of lamotrigine] in Healthy, Adult, Human Subjects Under Fed Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2013

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Bipolar disorders; Epilepsy; Lennox-Gastaut syndrome; Major depressive disorder; Schizophrenia; Seizures
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top